WDFY3 and Alzheimer disease: Another variant (rs17009220, P = 0.00484, http://www.gwascentral.org/marker/HGVM16286779/results?t=2) in WDFY3 exhibited nominally significant interaction (SNP*APOE ε4) in an AD case-control GWAS study.[27]